Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.

Welcome to the American Economic Journal - Applied Economics, a premier publication in the field of applied economics that strives to provide scholars and practitioners with cutting-edge research and insights. Published by the American Economic Association, this journal ranks in the top quartile (Q1) of Economics, Econometrics, and Finance categories as of 2023, reflecting its significant impact and relevance in the field. With a notable Scopus ranking of #5 out of 288 in General Economics and a distinguished percentile of 98th, this journal serves as a vital resource for advancing knowledge in economic theory and its application to real-world issues. Although not open access, it remains accessible to a broad audience, and welcomes submissions that explore innovative methodologies and empirical analyses that bridge theory and practice. Spanning from 2009 to 2024, the journal not only supports rigorous academic discourse but also plays a crucial role in shaping the discourse around effective economic policy. We invite researchers, professionals, and students in the field to engage with the high-quality work published within these pages.

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

Journal of the Economics of Ageing, published by ELSEVIER, is a leading international journal dedicated to exploring the economic aspects of ageing in the global context. With an ISSN of 2212-828X, it aims to provide a platform for innovative research that addresses the socio-economic implications of demographic shifts, particularly those related to life-span and life-course studies. Since its inception in 2013, the journal has rapidly established itself within the Q2 category in both the Economics and Econometrics and Life-span and Life-course Studies fields, reflecting its significant contribution to these disciplines. Based in the Netherlands, this journal is indexed with a respectable percentile ranking, such as 69th in Life-span and Life-course Studies, confirming its value to researchers and professionals alike. Committed to disseminating impactful research, the Journal of the Economics of Ageing ultimately seeks to influence policy and funding decisions that shape the future of ageing populations.

American Economic Journal - Economic Policy, published by the American Economic Association, stands at the forefront of economic research, focusing on significant policy implications and evidence-based evaluations. With an ISSN of 1945-7731 and an E-ISSN of 1945-774X, this esteemed journal has maintained its influence and credibility in the field since its inception in 2009. Ranked in the Q1 category for Economics, Econometrics and Finance and ranking #7 out of 288 in Scopus, it boasts a remarkable 97th percentile ranking, making it a premier source for cutting-edge research and policy discussion. The journal's rigorous peer-reviewed articles aim to bridge the gap between academic research and real-world economic policy, serving as an essential resource for researchers, professionals, and students who seek to engage with and contribute to the evolving landscape of economic policy. With open access options not currently available, readers are encouraged to subscribe or access articles through academic institutions for comprehensive insights into the economic challenges and innovations shaping our world.

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

JOURNAL OF PUBLIC ECONOMICS is a leading academic journal published by ELSEVIER SCIENCE SA, dedicated to the field of public economics, which encompasses a broad range of topics including taxation, government expenditure, and the effects of public policies on the economy. With an impressive impact factor reflected by its prestigious Q1 category rankings in both Economics and Finance, this journal is recognized as a vital resource for researchers and practitioners alike. Its robust Scopus rankings place it in the top percentile, with Finance ranked #8 out of 317 and Economics ranked #19 out of 716, demonstrating its influential role in advancing knowledge and fostering discourse within its discipline. Covering the period from 1972 through 2024, the journal publishes original research and insightful reviews that encourage evidence-based policy-making, making it an essential read for those seeking to deepen their understanding of the intersections between economics and public policy. Please note that the journal operates under a subscription model of access, ensuring high-quality content is readily available to its readership.

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.